Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 2
2012 3
2013 9
2014 2
2015 4
2016 7
2017 11
2018 11
2019 16
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
Ali MY, Jannat S, Edraki N, Das S, Chang WK, Kim HC, Park SK, Chang MS. Ali MY, et al. Among authors: edraki n. Chem Biol Interact. 2019 Aug 25;309:108707. doi: 10.1016/j.cbi.2019.06.020. Epub 2019 Jun 11. Chem Biol Interact. 2019. PMID: 31194956
5-Oxo-hexahydroquinoline: an attractive scaffold with diverse biological activities.
Ranjbar S, Edraki N, Firuzi O, Khoshneviszadeh M, Miri R. Ranjbar S, et al. Among authors: edraki n. Mol Divers. 2019 May;23(2):471-508. doi: 10.1007/s11030-018-9886-4. Epub 2018 Nov 2. Mol Divers. 2019. PMID: 30390186 Review.
Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
Iraji A, Khoshneviszadeh M, Firuzi O, Khoshneviszadeh M, Edraki N. Iraji A, et al. Among authors: edraki n. Bioorg Chem. 2020 Apr;97:103649. doi: 10.1016/j.bioorg.2020.103649. Epub 2020 Feb 4. Bioorg Chem. 2020. PMID: 32101780 Review.
Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
Vafadarnejad F, Mahdavi M, Karimpour-Razkenari E, Edraki N, Sameem B, Khanavi M, Saeedi M, Akbarzadeh T. Vafadarnejad F, et al. Among authors: edraki n. Bioorg Chem. 2018 Apr;77:311-319. doi: 10.1016/j.bioorg.2018.01.013. Epub 2018 Jan 31. Bioorg Chem. 2018. PMID: 29421707
Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives.
Rastegari A, Nadri H, Mahdavi M, Moradi A, Mirfazli SS, Edraki N, Moghadam FH, Larijani B, Akbarzadeh T, Saeedi M. Rastegari A, et al. Among authors: edraki n. Bioorg Chem. 2019 Mar;83:391-401. doi: 10.1016/j.bioorg.2018.10.065. Epub 2018 Oct 30. Bioorg Chem. 2019. PMID: 30412794
Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
Najafi Z, Mahdavi M, Saeedi M, Karimpour-Razkenari E, Edraki N, Sharifzadeh M, Khanavi M, Akbarzadeh T. Najafi Z, et al. Among authors: edraki n. Bioorg Chem. 2019 Mar;83:303-316. doi: 10.1016/j.bioorg.2018.10.056. Epub 2018 Oct 28. Bioorg Chem. 2019. PMID: 30396115
5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
Ranjbar S, Khonkarn R, Moreno A, Baubichon-Cortay H, Miri R, Khoshneviszadeh M, Saso L, Edraki N, Falson P, Firuzi O. Ranjbar S, et al. Among authors: edraki n. Toxicol Appl Pharmacol. 2019 Jan 1;362:136-149. doi: 10.1016/j.taap.2018.10.025. Epub 2018 Nov 2. Toxicol Appl Pharmacol. 2019. PMID: 30391378
Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease.
Iraji A, Firuzi O, Khoshneviszadeh M, Nadri H, Edraki N, Miri R. Iraji A, et al. Among authors: edraki n. Bioorg Chem. 2018 Apr;77:223-235. doi: 10.1016/j.bioorg.2018.01.017. Epub 2018 Jan 16. Bioorg Chem. 2018. PMID: 29367079
Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities.
Ghobadian R, Mahdavi M, Nadri H, Moradi A, Edraki N, Akbarzadeh T, Sharifzadeh M, Bukhari SNA, Amini M. Ghobadian R, et al. Among authors: edraki n. Eur J Med Chem. 2018 Jul 15;155:49-60. doi: 10.1016/j.ejmech.2018.05.031. Epub 2018 May 23. Eur J Med Chem. 2018. PMID: 29857276
Design, synthesis, cytotoxicity evaluation and docking studies of 1,2,4-triazine derivatives bearing different arylidene-hydrazinyl moieties as potential mTOR inhibitors.
Ranjbar S, Edraki N, Khoshneviszadeh M, Foroumadi A, Miri R, Khoshneviszadeh M. Ranjbar S, et al. Among authors: edraki n. Res Pharm Sci. 2018 Feb;13(1):1-11. doi: 10.4103/1735-5362.220962. Res Pharm Sci. 2018. PMID: 29387106 Free PMC article.
71 results
Jump to page
Feedback